BioCareSD is the original specialty distributor, known for outstanding customer service. We feature an ever-expanding portfolio of specialty products in hemotology, immunology, neurology, orphan and other ultra-rare disease states.
Always at your service.
February 2021 PRODUCT CATALOG
1
A letter from the President
Hello!
Our team at BioCareSD is excited with anticipation at the great additions ahead for the BioCare companies and the positive changes that will impact you, our valued customer.
Over the last year, our team has been busy expanding our product portfolio, developing more service offerings, and enhancing our facilities, all of which will deliver an even greater customer service experience.
We are proud to be one of the nation’s leading specialty distributors, known for our unparalleled customer service. Our customer support team and local, field-based account management teams are available 24 hours a day, 7 days a week, 365 days a year. We built our reputation on being a valued partner to our customers, delivering the best possible care to patients all over the country through agility and wide-reaching distribution capabilities. The foundation of all BioCare Companies is our approach to serving our customers. We will do whatever it takes to deliver life-saving therapeutics with both speed and accuracy — whenever and wherever they are needed. We are proud to support our partners in their mission to save lives.
Warm regards,
Linda Matthews President
3
What sets us apart from other specialty distributors?
BioCareSD® exists to provide fast and easy access to life-saving medications. As a trusted partner to our customers, the team at BioCareSD is relentlessly committed to expert solutions that deliver every time. Our customers are our main focus.
BioCareSD is one of the nation’s leading specialty distributors, known for our unparalleled customer service. Our customer support team and local, field- based account management teams are available 24 hours a day, 7 days a week, 365 days a year. We feature an ever-expanding portfolio of specialty products for hematology, thrombophilia, immunology, neurology, orphan and other ultra-rare diseases. BioCareSD is an Authorized Distributor of Record for all the manufacturers we represent, so you can depend on the quality of our products. We are committed to being the industry’s most trusted healthcare partner by providing customer-oriented solutions, unmatched service levels and a unique distribution network to ensure the highest-quality patient care.
Staff onsite 24/7, 365 days a year
Guaranteed next-day and emergency same-day delivery
STAT and emergency deliveries are our specialty
Ability to reach anywhere in the country in 4 to 6 hours
We have an agile and wide-reaching distribution network
We are always at your service.
Spokane
Seattle
Milwaukee
Providence
Ramsey
Montvale
Pittsburgh
Westbury
Dayton
Denver
Kansas City
Las Vegas
Memphis
Always at your service.
Phoenix
El Paso
Dallas
Lafayette
Miami
5
FOR PATIENTS AT RISK OF INFECTION
Inside every brave patient living with primary humoral immunodeficiency (PI) is the desire to live the healthiest life possible. Introducing ASCENIV™, formerly known as RI-002, developed to help protect patients with PI. IT’sWHAT’s INSIDE THATCOUNTS ASCENIV™ is manufactured through a patented process using source plasma, which is acquired from donors screened using a microneutralization assay to detect and identify which donors possess naturally occurring neutralizing antibody titers to respiratory syncytial virus (RSV) 1 ◊ Plasma pool is derived from a minimum of 1000 unique donors and blends normal source plasma with RSV plasma In a 1-year, prospective, open-label, nonrandomized, multicenter, phase 3 study evaluating the efficacy and safety of ASCENIV™ in adult and pediatric patients with PI 2 : ◊ ZERO serious bacterial infections ◊ Secondary endpoint results: • 1.7 missed days of work/school/day care • <1 unscheduled medical visits • No hospitalizations †
AN igiv FOR PATIENTS WITH PRIMARY HUMORAL IMMUNODEFICIENCY (PI)
Indication ASCENIV (immune globulin intravenous, human) is a 10% immune globulin liquid for intravenous injection, indicated for the treatment of primary humoral immunodeficiency (PI) in adults and adolescents (12 to 17 years of age). PI includes, but is not limited to, the humoral immune defect in congenital agammaglobulinemia, common variable immunodeficiency (CVID), X linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies (SCID).
Contraindications ASCENIV is contraindicated in:
Aseptic meningitis syndrome (AMS) may occur with IGIV treatments, including ASCENIV. AMS usually begins within several hours to 2 days following IGIV treatment. AMS may occur more frequently in association with high doses (2 g/kg) and/or rapid infusion of IGIV. Conduct a thorough neurological examination on patients exhibiting signs and symptoms of AMS, including cerebrospinal fluid (CSF) studies, to rule out other causes of meningitis. IGIV products, including ASCENIV, may contain blood group antibodies that can act as hemolysins and induce in vivo coating of red blood cells (RBCs) with immunoglobulin, causing a positive direct antiglobulin reaction and hemolysis. Monitor patients for clinical signs and symptoms of hemolysis, including appropriate confirmatory laboratory testing. Non-cardiogenic pulmonary edema may occur with IV administered IG. Monitor patients for pulmonary adverse reactions. If suspected, perform appropriate tests for presence of anti-neutrophil in both product and patient serum. May be managed using oxygen therapy with adequate ventilatory support. Because ASCENIV is made from human blood, it may carry a risk of transmitting infectious agents, e.g., viruses, the variant Creutzfeldt-Jakob disease (vCJD) and theoretically, the Creutzfeldt-Jakob disease (CJD) agent. All infections suspected by a physician to possibly have been transmitted by this product should be reported to ADMA Biologics at (1-800-458-4244) . After infusion of immunoglobulin, the transitory rise of the various passively transferred antibodies in the patient’s blood may yield positive serological testing results, with the potential for misleading interpretation. Passive transmission of antibodies to erythrocyte antigens (e.g., A, B, and D) may cause a positive direct or indirect antiglobulin (Coombs’) test. Adverse Reactions The most common adverse reactions to ASCENIV ( ≥ 5% of study subjects) were headache, sinusitis, diarrhea, gastroenteritis viral, nasopharyngitis, upper respiratory tract infection, bronchitis, and nausea. You are encouraged to report side effects of prescription drugs to ADMA Biologics @ 1-800-458-4244 or the FDA. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088.
• Patients who have had an anaphylactic or severe systemic reaction to the administration of human immune globulin. • IgA-deficiency patients with antibodies to IgA and a history of hypersensitivity. Warnings and Precautions Severe hypersensitivity reactions may occur with IGIV products, including ASCENIV. In case of hypersensitivity, discontinue ASCENIV infusion immediately and institute appropriate treatment. Patients with known antibodies to IgA may have a greater risk of developing potentially severe hypersensitivity and anaphylactic reactions. Thrombosis may occur following treatment with immunoglobulin products and in the absence of known risk factors. Consider baseline assessment of blood viscosity in patients at risk for hyperviscosity and ensure adequate hydration before administration. For patients at risk of thrombosis, administer ASCENIV at the minimum dose and infusion rate practicable. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity. Acute renal dysfunction/failure, osmotic nephrosis, and death may occur upon use of human IGIV products. Ensure that patients are not volume depleted before administering ASCENIV. Periodic monitoring of renal function and urine output is particularly important in patients judged to be at increased risk of developing acute renal failure. Assess renal function, including measurement of blood urea nitrogen (BUN) and serum creatinine, before the initial infusion of ASCENIV and at appropriate intervals thereafter. Discontinue ASCENIV if renal function deteriorates. In at risk patients, administer ASCENIV at the minimum infusion rate practicable. Hyperproteinemia, increased serum viscosity, and hyponatremia or pseudohyponatremia may occur in patients receiving IGIV treatment, including ASCENIV. It is critical to clinically distinguish true hyponatremia from a pseudohyponatremia that is associated with or causally related to hyperproteinemia. Treatment aimed at decreasing serum free water in patients with pseudohyponatremia may lead to volume depletion, a further increase in serum viscosity, and a possible predisposition to thrombotic events.
INTRODUCING
Visit asceniv.com for more information
ADMA BIOLOGICS PATENTS ISSUED 9,107,906 - 9,714,283 - 9,815,886 IGIV=immune globulin intravenous.
Important Safety Information for ASCENIV TM (Immune Globulin Intravenous [Human] – slra 10% Liquid)
WARNING: THROMBOSIS, RENAL DYSFUNCTION AND ACUTE RENAL FAILURE Thrombosis may occur with immune globulin (IGIV) products, including ASCENIV. Risk factors may include: advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling central vascular catheters, hyperviscosity, and cardiovascular risk factors. Thrombosis may occur in the absence of known risk factors. Renal dysfunction, acute renal failure, osmotic nephrosis, and death may occur with the administration of Immune Globulin Intravenous (Human) (IGIV) products in predisposed patients. Renal dysfunction and acute renal failure occur more commonly in patients receiving IGIV products containing sucrose. ASCENIV does not contain sucrose. For patients at risk of thrombosis, renal dysfunction or renal failure, administer ASCENIV at the minimum dose and infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity.
Study Design: A 52-week, prospective, open-label, nonrandomized, multicenter, phase 3 study that evaluated the efficacy and safety of ASCENIV (RI-002) in 59 patients with PI. IV infusions were administered at doses of 300 to 800 mg/kg every 3 or 4 weeks. Primary efficacy endpoint was the demonstration of a serious bacterial infection (SBI) rate of less than 1.0 per person-year during the 52-week treatment period. Secondary efficacy endpoints included number of missed days of work/school/activity due to infection, unscheduled visits to the physician, and days hospitalized due to infection. 2 † One patient hospitalized from study group due to post-op local wound infection from elective surgery. For additional safety information about ASCENIV, please click here to see full Prescribing Information.
References: 1. Wasserman RL, Garcia D, Greener BN, et al. Manufacturing process optimization of ADMA Biologics’ intravenous immunoglobulin products, BIVIGAM® and ASCENIV™. Immunotherapy. 2019;11(16):1423-1433. 2. ASCENIV™ Prescribing Information, ADMA Biologics, 2019.
© 2020 ADMA Biologics. All rights reserved. ASCENIV™ is a trademark of ADMA Biologics. Visit admabiologics.com
7
Always at your service.
9
AP ALBUMIN PRODUCTS Product Name Package Size NDC #
HP HEMATOLOGY PRODUCTS Product Name Package Size NDC #
Product Category Subcategory Derivation
Product Category Subcategory Derivation
Presentation
Manufacturer
Presentation
Manufacturer
ANTI-IN- HIBITOR COAGULANT COMPL ANTI-IN- HIBITOR COAGULANT COMPL ANTI-IN- HIBITOR COAGULANT COMPL ANTI-IN- HIBITOR COAGULANT COMPL
ALBUMIN/PLASMA PROTEIN FRACTION
MONOCLONAL ANTIBODY
HEMLIBRA
30 MG 50242-0920-01
VIAL
NONFACTOR
GENENTECH USA, INC.
ALBUKED
25% 50ML 76125-0792-25
VIAL
ALBUMIN
N/A
PLASMA
KEDRION BIOPHARMA
ALBUKED
25% 100ML 76125-0792-10
VIAL
ALBUMIN
N/A
PLASMA
KEDRION BIOPHARMA
MONOCLONAL ANTIBODY
HEMLIBRA
60 MG 50242-0921-01
VIAL
NONFACTOR
GENENTECH USA, INC.
ALBUKED
5% 250ML 76125-0790-25
VIAL
ALBUMIN
N/A
PLASMA
KEDRION BIOPHARMA
ALBUMIN
25% 50ML 68982-0643-01
VIAL
ALBUMIN
N/A
PLASMA
OCTAPHARMA USA
MONOCLONAL ANTIBODY
ALBUMIN
20% 100ML 68982-0633-02
VIAL
ALBUMIN
N/A
PLASMA
OCTAPHARMA USA
HEMLIBRA
105 MG 50242-0922-01
VIAL
NONFACTOR
GENENTECH USA, INC.
ALBUMIN
25% 100ML 68982-0643-02
VIAL
ALBUMIN
N/A
PLASMA
OCTAPHARMA USA
ALBUMIN
5% 250ML 68982-0623-02
VIAL
ALBUMIN
N/A
PLASMA
OCTAPHARMA USA
MONOCLONAL ANTIBODY
HEMLIBRA
150 MG 50242-0923-01
VIAL
NONFACTOR
GENENTECH USA, INC.
ALBUMIN
5% 500ML 68982-0623-03
VIAL
ALBUMIN
N/A
PLASMA
OCTAPHARMA USA
ANTITHROMBIN
ALBUMINAR
25% 50ML 00053-7680-32
VIAL
ALBUMIN
N/A
PLASMA
CSL BEHRING LLC
THROMBATE III
500 IU 13533-0602-50
VIAL
COAGULANT ANTITHROM- BIN
PLASMA
GRIFOLS USA, LLC
ALBUMINAR
25% 100ML 00053-7680-33
VIAL
ALBUMIN
N/A
PLASMA
CSL BEHRING LLC
FACTOR I
ALBURX
25% 50ML 44206-0251-05
VIAL
ALBUMIN
N/A
PLASMA
CSL BEHRING LLC
FIBRYGA
1 GRAM 68982-0347-01
VIAL
COAGULANT FACTOR I
PLASMA
OCTAPHARMA USA
ALBURX
25% 100ML 44206-0251-10
VIAL
ALBUMIN
N/A
PLASMA
CSL BEHRING LLC
RIASTAP
1000 IU 63833-0891-51
VIAL
COAGULANT FACTOR I
PLASMA
CSL BEHRING LLC
ALBURX
5% 250ML 44206-0310-25
VIAL
ALBUMIN
N/A
PLASMA
CSL BEHRING LLC
FACTOR IX
ALBURX
5% 500ML 44206-0310-50
VIAL
ALBUMIN
N/A
PLASMA
CSL BEHRING LLC
ALPHANINE
500 IU 68516-3607-02
VIAL
COAGULANT FACTOR IX PLASMA
GRIFOLS USA, LLC
ALBUTEIN
25% 20ML
68516-5216-05
VIAL
ALBUMIN
N/A
PLASMA
GRIFOLS USA, LLC
ALPHANINE
1000 IU 68516-3608-02
VIAL
COAGULANT FACTOR IX PLASMA
GRIFOLS USA, LLC
ALBUTEIN
5% 50ML
68516-5214-05
VIAL
ALBUMIN
N/A
PLASMA
GRIFOLS USA, LLC
ALPHANINE
1500 IU 68516-3609-02
VIAL
COAGULANT FACTOR IX PLASMA
GRIFOLS USA, LLC
ALBUTEIN
25% 50ML
68516-5216-01
VIAL
ALBUMIN
N/A
PLASMA
GRIFOLS USA, LLC
ALPROLIX
250 IU 71104-0966-01
VIAL
COAGULANT FACTOR IX RECOMBINANT BIOVERATIV U.S., LLC
ALBUTEIN
25% 100ML 68516-5216-02
VIAL
ALBUMIN
N/A
PLASMA
GRIFOLS USA, LLC
ALPROLIX
500 IU 71104-0911-01
VIAL
COAGULANT FACTOR IX RECOMBINANT BIOVERATIV U.S., LLC
ALBUTEIN
5% 250ML
68516-5214-01
VIAL
ALBUMIN
N/A
PLASMA
GRIFOLS USA, LLC
ALPROLIX
1000 IU 71104-0922-01
VIAL
COAGULANT FACTOR IX RECOMBINANT BIOVERATIV U.S., LLC
ALBUTEIN
5% 500ML 68516-5214-02
VIAL
ALBUMIN
N/A
PLASMA
GRIFOLS USA, LLC
ALPROLIX
2000 IU 71104-0933-01
VIAL
COAGULANT FACTOR IX RECOMBINANT BIOVERATIV U.S., LLC
FLEXBUMIN
25% 50ML 00944-0493-01
BAG
ALBUMIN
N/A
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
ALPROLIX
3000 IU 71104-0944-01
VIAL
COAGULANT FACTOR IX RECOMBINANT BIOVERATIV U.S., LLC
ALPROLIX
4000 IU 71104-0977-01
VIAL
COAGULANT FACTOR IX RECOMBINANT BIOVERATIV U.S., LLC
FLEXBUMIN
25% 100ML 00944-0493-02
BAG
ALBUMIN
N/A
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
BENEFIX RT
250 IU 58394-0633-03
VIAL
COAGULANT FACTOR IX RECOMBINANT
PFIZER, INC.
BENEFIX RT
500 IU 58394-0634-03
VIAL
COAGULANT FACTOR IX RECOMBINANT
PFIZER, INC.
FLEXBUMIN
5% 250ML 00944-0495-05
BAG
ALBUMIN
N/A
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
BENEFIX RT
1000 IU 58394-0635-03
VIAL
COAGULANT FACTOR IX RECOMBINANT
PFIZER, INC.
BENEFIX RT
2000 IU 58394-0636-03
VIAL
COAGULANT FACTOR IX RECOMBINANT
PFIZER, INC.
HP HEMATOLOGY PRODUCTS Product Name Package Size NDC #
BENEFIX RT
3000 IU 58394-0637-03
VIAL
COAGULANT FACTOR IX RECOMBINANT
PFIZER, INC.
Product Category Subcategory Derivation
IDELVION
250 IU 69911-0864-02
VIAL
COAGULANT FACTOR IX RECOMBINANT
CSL BEHRING LLC
Presentation
Manufacturer
IDELVION
500 IU 69911-0865-02
VIAL
COAGULANT FACTOR IX RECOMBINANT
CSL BEHRING LLC
ANTI-INHIBITOR COAGULANT COMPLEX
IDELVION
1000 IU 69911-0866-02
VIAL
COAGULANT FACTOR IX RECOMBINANT
CSL BEHRING LLC
ANTI-IN- HIBITOR COAGULANT COMPL ANTI-IN- HIBITOR COAGULANT COMPL ANTI-IN- HIBITOR COAGULANT COMPL
FEIBA
1000 IU 64193-0424-02
VIAL
INHIBITORS
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
IDELVION
2000 IU 69911-0867-02
VIAL
COAGULANT FACTOR IX RECOMBINANT
CSL BEHRING LLC
IDELVION
4000 IU 69911-0869-02
VIAL
COAGULANT FACTOR IX RECOMBINANT
CSL BEHRING LLC
MONONINE
1000 IU 00053-6233-02
VIAL
COAGULANT FACTOR IX PLASMA
CSL BEHRING LLC
FEIBA
2000 IU 64193-0425-02
VIAL
INHIBITORS
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
REBINYN
500 IU 00169-7905-01
VIAL
COAGULANT FACTOR IX RECOMBINANT NOVO NORDISK INC.
REBINYN
1000 IU 00169-7901-01
VIAL
COAGULANT FACTOR IX RECOMBINANT NOVO NORDISK INC.
FEIBA
500 IU 64193-0426-02
VIAL
INHIBITORS
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
REBINYN
2000 IU 00169-7902-01
VIAL
COAGULANT FACTOR IX RECOMBINANT NOVO NORDISK INC.
11
HP HEMATOLOGY PRODUCTS Product Name Package Size NDC #
HP HEMATOLOGY PRODUCTS Product Name Package Size NDC #
Product Category Subcategory Derivation
Product Category Subcategory Derivation
Presentation
Manufacturer
Presentation
Manufacturer
ADYNOVATE
1500 IU
00944-4627-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
RIXUBIS
250 IU 00944-3026-02
VIAL
COAGULANT FACTOR IX RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
1801 - 2500 IU 00944-4625-01
ADYNOVATE
VIAL
COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
RIXUBIS
500 IU 00944-3028-02
VIAL
COAGULANT FACTOR IX RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
ADYNOVATE
3000 IU 00944-4628-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
RIXUBIS
1000 IU 00944-3030-02
VIAL
COAGULANT FACTOR IX RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
AFSTYLA
250 IU
69911-0474-02
VIAL
COAGULANT FACTOR VIII RECOMBINANT
CSL BEHRING LLC
AFSTYLA
500 IU
69911-0475-02
VIAL
COAGULANT FACTOR VIII RECOMBINANT
CSL BEHRING LLC
RIXUBIS
2000 IU 00944-3032-02
VIAL
COAGULANT FACTOR IX RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
AFSTYLA
1000 IU
69911-0476-02
VIAL
COAGULANT FACTOR VIII RECOMBINANT
CSL BEHRING LLC
RIXUBIS
3000 IU 00944-3034-02
VIAL
COAGULANT FACTOR IX RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
AFSTYLA
2000 IU
69911-0477-02
VIAL
COAGULANT FACTOR VIII RECOMBINANT
CSL BEHRING LLC
AFSTYLA
3000 IU
69911-0478-02
VIAL
COAGULANT FACTOR VIII RECOMBINANT
CSL BEHRING LLC
FACTOR IX COMPLEX
AFSTYLA
2500 IU
69911-0481-02
VIAL
COAGULANT FACTOR VIII RECOMBINANT
CSL BEHRING LLC
KCENTRA
500 IU 63833-0386-02
VIAL
COAGULANT FACTOR IX COMPLEX PLASMA COAGULANT FACTOR IX COMPLEX PLASMA COAGULANT FACTOR IX COMPLEX PLASMA COAGULANT FACTOR IX COMPLEX PLASMA
CSL BEHRING LLC
ELOCTATE
250 IU
71104-0801-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC
KCENTRA
1000 IU 63833-0387-02
VIAL
CSL BEHRING LLC
ELOCTATE
500 IU
71104-0802-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC
PROFILNINE
500 IU 68516-3207-01
VIAL
GRIFOLS USA, LLC
ELOCTATE
700 IU
71104-0803-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC
ELOCTATE
1000 IU
71104-0804-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC
PROFILNINE
1000 IU 68516-3208-02
VIAL
GRIFOLS USA, LLC
ELOCTATE
1500 IU
71104-0805-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC
FACTOR VIIA
ELOCTATE
2000 IU
71104-0806-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC
NOVOSEVEN RT
1 MG 00169-7201-01
VIAL
INHIBITORS FACTOR VIIA RECOMBINANT NOVO NORDISK INC.
ELOCTATE
3000 IU
71104-0807-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC
NOVOSEVEN RT
2 MG 00169-7202-01
VIAL
INHIBITORS FACTOR VIIA RECOMBINANT NOVO NORDISK INC.
ELOCTATE
4000 IU
71104-0808-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC
NOVOSEVEN RT
5 MG 00169-7205-01
VIAL
INHIBITORS FACTOR VIIA RECOMBINANT NOVO NORDISK INC.
ELOCTATE
5000 IU
71104-0809-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC
NOVOSEVEN RT
8 MG 00169-7208-01
VIAL
INHIBITORS FACTOR VIIA RECOMBINANT NOVO NORDISK INC.
ELOCTATE
6000 IU
71104-0810-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT BIOVERATIV U.S., LLC
SEVENFACT
1MG
71127-1000-01
VIAL
INHIBITORS FACTOR VIIA RECOMBINANT
HEMA BIOLOGICS
ESPEROCT
500 IU
00169-8500-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.
SEVENFACT
5MG
71127-5000-01
VIAL
INHIBITORS FACTOR VIIA RECOMBINANT
HEMA BIOLOGICS
FACTOR VIII
ESPEROCT
1000 IU
00169-8100-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.
1801 IU - 2400 IU 00944-3045-10 2401 IU - 3600 IU 00944-3046-10 3601 IU - 4800 IU 00944-3047-10
ADVATE
VIAL
COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
ESPEROCT
1500 IU
00169-8150-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.
ESPEROCT
2000 IU 00169-8200-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.
ADVATE
VIAL
COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
ESPEROCT
3000 IU
00169-8300-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.
ADVATE
VIAL
COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
220 IU – 400 IU 401 IU – 800 IU 801 IU – 1700 IU
HEMOFIL
00944-3940-02
VIAL
COAGULANT FACTOR VIII
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
200 IU - 400 IU 401 IU - 800 IU 801 IU - 1200 IU 1201 IU - 1800 IU 401 IU - 800 IU
ADVATE
00944-3051-02
VIAL
COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
HEMOFIL
00944-3942-02
VIAL
COAGULANT FACTOR VIII
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
ADVATE
00944-3052-02
VIAL
COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
HEMOFIL
00944-3944-02
VIAL
COAGULANT FACTOR VIII
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
ADVATE
00944-3053-02
VIAL
COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
1501 IU – 2000 IU 00944-3946-02
HEMOFIL
VIAL
COAGULANT FACTOR VIII
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
ADVATE
00944-3054-02
VIAL
COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
JIVI
500 IU
00026-3942-25
VIAL
COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION
ADYNOVATE
00944-4623-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
JIVI
1000 IU
00026-3944-25
VIAL
COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION
ADYNOVATE
750 IU
00944-4626-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
JIVI
2000 IU 00026-3946-25
VIAL
COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION
801 IU - 1250 IU
ADYNOVATE
00944-4624-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
JIVI
3000 IU 00026-3948-25
VIAL
COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION
13
HP HEMATOLOGY PRODUCTS Product Name Package Size NDC #
HP HEMATOLOGY PRODUCTS Product Name Package Size NDC #
Product Category Subcategory Derivation
Product Category Subcategory Derivation
Presentation
Manufacturer
Presentation
Manufacturer
KOATE
250 IU
76125-0256-20
VIAL
COAGULANT FACTOR VIII
PLASMA
KEDRION BIOPHARMA
XYNTHA SOLOFUSE
250 IU
58394-0022-03
VIAL
COAGULANT FACTOR VIII RECOMBINANT
PFIZER, INC.
KOATE
500 IU
76125-0668-30
VIAL
COAGULANT FACTOR VIII
PLASMA
KEDRION BIOPHARMA
XYNTHA SOLOFUSE
500 IU
58394-0023-03
VIAL
COAGULANT FACTOR VIII RECOMBINANT
PFIZER, INC.
KOATE
1000 IU
76125-0676-50
VIAL
COAGULANT FACTOR VIII
PLASMA
KEDRION BIOPHARMA
XYNTHA SOLOFUSE
1000 IU
58394-0024-03
VIAL
COAGULANT FACTOR VIII RECOMBINANT
PFIZER, INC.
KOGENATE
250 IU
00026-3782-25
VIAL
COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION
XYNTHA SOLOFUSE
2000 IU 58394-0025-03
VIAL
COAGULANT FACTOR VIII RECOMBINANT
PFIZER, INC.
KOGENATE
500 IU
00026-3783-35
VIAL
COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION
XYNTHA SOLOFUSE
3000 IU 58394-0016-03
VIAL
COAGULANT FACTOR VIII RECOMBINANT
PFIZER, INC.
KOGENATE
1000 IU
00026-3785-55
VIAL
COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION
FACTOR VIII WITH VON WILLEBRAND FACTOR
KOGENATE
2000 IU 00026-3786-65
VIAL
COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION
KOGENATE
3000 IU 00026-3787-75
VIAL
COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION
ALPHANATE
250 IU
68516-4611-01
VIAL
COAGULANT FACTOR VIII WITH VWF
PLASMA
GRIFOLS USA, LLC
KOVALTRY
250 IU
00026-3821-25
VIAL
COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION
ALPHANATE
500 IU
68516-4612-01
VIAL
COAGULANT FACTOR VIII WITH VWF
PLASMA
GRIFOLS USA, LLC
KOVALTRY
500 IU
00026-3822-25
VIAL
COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION
KOVALTRY
1000 IU
00026-3824-25
VIAL
COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION
ALPHANATE
1000 IU
68516-4613-02
VIAL
COAGULANT FACTOR VIII WITH VWF
PLASMA
GRIFOLS USA, LLC
KOVALTRY
2000 IU 00026-3826-50
VIAL
COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION
KOVALTRY
3000 IU 00026-3828-50
VIAL
COAGULANT FACTOR VIII RECOMBINANT BAYER CORPORATION
ALPHANATE
1500 IU
68516-4614-02
VIAL
COAGULANT FACTOR VIII WITH VWF
PLASMA
GRIFOLS USA, LLC
NOVOEIGHT
250 IU
00169-7825-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.
ALPHANATE
2000 IU
68516-4615-02
VIAL
COAGULANT FACTOR VIII WITH VWF
PLASMA
GRIFOLS USA, LLC
NOVOEIGHT
500 IU
00169-7850-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.
NOVOEIGHT
1000 IU
00169-7810-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.
HUMATE-P
600 RCOF
63833-0615-02
VIAL
COAGULANT FACTOR VIII WITH VWF
PLASMA
CSL BEHRING LLC
NOVOEIGHT
1500 IU
00169-7815-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.
NOVOEIGHT
2000 IU
00169-7820-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.
HUMATE-P
1200 RCOF 63833-0616-02
VIAL
COAGULANT FACTOR VIII WITH VWF
PLASMA
CSL BEHRING LLC
NOVOEIGHT
3000 IU
00169-7830-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT NOVO NORDISK INC.
NUWIQ
250 IU
68982-0139-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT
OCTAPHARMA USA
HUMATE-P
2400 RCOF 63833-0617-02
VIAL
COAGULANT FACTOR VIII WITH VWF
PLASMA
CSL BEHRING LLC
NUWIQ
500 IU
68982-0141-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT
OCTAPHARMA USA
WILATE
500 RCOF
68982-0182-01
VIAL
COAGULANT FACTOR VIII WITH VWF
PLASMA
OCTAPHARMA USA
NUWIQ
1000 IU
68982-0143-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT
OCTAPHARMA USA
NUWIQ
2000 IU
68982-0145-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT
OCTAPHARMA USA
WILATE
1000 RCOF 68982-0182-02
VIAL
COAGULANT FACTOR VIII WITH VWF
PLASMA
OCTAPHARMA USA
NUWIQ
2500 IU
68982-0147-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT
OCTAPHARMA USA
FACTOR X
NUWIQ
3000 IU
68982-0149-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT
OCTAPHARMA USA
BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES
NUWIQ
4000 IU
68982-0151-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT
OCTAPHARMA USA
COAGADEX
250 IU
64208-7752-01
VIAL
COAGULANT FACTOR X PLASMA
1-PACK 500 AU
OBIZUR
00944-5001-01
VIAL
INHIBITORS FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
COAGADEX
500 IU
64208-7753-01
VIAL
COAGULANT FACTOR X PLASMA
FACTOR XA
220 IU – 400 IU
RECOMBINATE
00944-2841-10
VIAL
COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
200 MG VIAL
CARTON: 4 VIALS/CTN COAGULANT FACTOR XA RECOMBINANT
PORTOLA PHARMACEUTICALS, INC.
ANDEXXA
69853-0102-01
401 IU – 800 IU
RECOMBINATE
00944-2842-10
VIAL
COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
FACTOR XIII
CORIFACT
1000 IU
63833-0518-02
VIAL
COAGULANT FACTOR XIII
PLASMA
CSL BEHRING LLC
801 IU – 1240 IU
RECOMBINATE
00944-2843-10
VIAL
COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
VON WILLEBRAND FACTOR
VON WIL- LEBRAND FACTOR VON WIL- LEBRAND FACTOR VON WIL- LEBRAND FACTOR VON WIL- LEBRAND FACTOR
1241 IU -1800 IU 00944-2844-10
RECOMBINATE
VIAL
COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
CABLIVI
11 MG
58468-0225-01
VIAL
COAGULANT
RECOMBINANT
SANOFI GENZYME
1801 IU– 2400 IU 00944-2845-10
RECOMBINATE
VIAL
COAGULANT FACTOR VIII RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
STIMATE
1.5MG
00053-6871-00
SPRAY COAGULANT
RECOMBINANT
CSL BEHRING LLC
XYNTHA
250 IU
58394-0012-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT
PFIZER, INC.
450 – 850 IU
XYNTHA
500 IU
58394-0013-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT
PFIZER, INC.
VONVENDI
00944-7551-02
VIAL
COAGULANT
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
XYNTHA
1000 IU
58394-0014-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT
PFIZER, INC.
900 – 1700 IU
VONVENDI
00944-7553-02
VIAL
COAGULANT
RECOMBINANT TAKEDA PHARMACEUTICALS AMERICAS, INC.
XYNTHA
2000 IU
58394-0015-01
VIAL
COAGULANT FACTOR VIII RECOMBINANT
PFIZER, INC.
15
HG IMMUNOOGY PRODUCTS - HYPERIMMUNE GLOBULIN Product Name Package Size NDC # Presentation Product Category Subcategory Derivation
IG IMMUNOOGY PRODUCTS - IMMUNOGLOBULIN Product Name Package Size NDC #
Manufacturer
Presentation Product Category Subcategory Derivation
Manufacturer
CYTOMEGALOVIRUS IMMUNE GLOBULIN
INTRAVENOUS IMMUNE GLOBULIN
CYTOGAM
2.5 GRAMS 44206-0532-11
VIAL
HYPER IMMUNE
IG
PLASMA SAOL THERAPEUTICS, INC.
ASCENIV
5 GRAM 69800-0250-01
VIAL
IVIG
IG
PLASMA
ADMA BIOLOGICS
ITRAMUSCULAR IMMUNE GLOBULIN
BIGAM
5 GRAM 69800-6502-01
VIAL
IVIG
IG
PLASMA
ADMA BIOLOGICS
GAMASTAN
2 ML
13533-0335-04
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
GAMMAGARD - LIQUID
1 GRAM 00944-2700-02
VIAL
IVIG
IG
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
GAMASTAN
10 ML
13533-0335-12
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
GAMMAGARD - LIQUID 2.5 GRAM 00944-2700-03
VIAL
IVIG
IG
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
HEPATITIS B IMMUNE GLOBULIN
GAMMAGARD - LIQUID
5 GRAM 00944-2700-04
VIAL
IVIG
IG
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
HEPAGAM
1 ML
70257-0052-51
VIAL
HYPER IMMUNE
IG
PLASMA SAOL THERAPEUTICS, INC.
HEPAGAM
5 ML
70257-0051-51
VIAL
HYPER IMMUNE
IG
PLASMA SAOL THERAPEUTICS, INC.
GAMMAGARD - LIQUID
10 GRAM 00944-2700-05
VIAL
IVIG
IG
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
NABI-HB
5ML
69800-4203-01
VIAL
HYPER IMMUNE
IG
PLASMA
ADMA BIOLOGICS
GAMMAGARD - LIQUID 20 GRAM 00944-2700-06
VIAL
IVIG
IG
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
RABIES IMMUNE GLOBULIN
GAMMAGARD - LIQUID 30 GRAM 00944-2700-07
VIAL
IVIG
IG
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
HYPERRAB
2 ML
13533-0618-02
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
GAMMAGARD - S/D
5 GRAM 00944-2656-03
VIAL
IVIG
IG
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
HYPERRAB
10 ML
13533-0618-10
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
GAMMAGARD - S/D
10 GRAM 00944-2658-04
VIAL
IVIG
IG
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
KEDRAB
2 ML
76125-0150-02
VIAL
HYPER IMMUNE
IG
PLASMA
KEDRION BIOPHARMA
GAMMAKED
1 GRAM 76125-0900-01
VIAL
IVIG
IG
PLASMA
KEDRION BIOPHARMA
KEDRAB
10 ML
76125-0150-10
VIAL
HYPER IMMUNE
IG
PLASMA
KEDRION BIOPHARMA
TETANUS IMMUNE GLOBULIN
GAMMAKED
5 GRAM 76125-0900-50
VIAL
IVIG
IG
PLASMA
KEDRION BIOPHARMA
HYPERTET
250 IU 13533-0634-02
SYRINGE HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
GAMMAKED
10 GRAM 76125-0900-10
VIAL
IVIG
IG
PLASMA
KEDRION BIOPHARMA
VARICELLA ZOSTER IMMUNE GLOBULIN
GAMMAKED
20 GRAM 76125-0900-20
VIAL
IVIG
IG
PLASMA
KEDRION BIOPHARMA
BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES
VARIZIG
125 IU 70257-0126-51
VIAL
HYPER IMMUNE
IG
PLASMA SAOL THERAPEUTICS, INC.
GAMMAPLEX 5%
5% 5 GRAM 64208-8234-06
VIAL
IVIG
IG
PLASMA
RHO(D) IMMUNE GLOBULIN
GAMMAPLEX 5%
5% 10 GRAM 64208-8234-07
VIAL
IVIG
IG
PLASMA
MICRHOGAM
1 PACK 00562-7806-01
SYRINGE
RH IMMUNE
N/A
PLASMA
KEDRION BIOPHARMA
GAMMAPLEX 5%
5% 20 GRAM 64208-8234-08
VIAL
IVIG
IG
PLASMA
RHOGAM
1 PACK 00562-7805-01
SYRINGE
RH IMMUNE
N/A
PLASMA
KEDRION BIOPHARMA
GAMMAPLEX 10%
10% 5 GRAM 64208-8235-05
VIAL
IVIG
IG
PLASMA
GAMMAPLEX 10%
10% 10 GRAM 64208-8235-06
VIAL
IVIG
IG
PLASMA
HYPERRHO
1500 IU 13533-0631-02
VIAL
RH IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
GAMMAPLEX 10%
10% 20 GRAM 64208-8235-07
VIAL
IVIG
IG
PLASMA
RHOPHYLAC
300 MCG 44206-0300-10 PACK, 10 SYRINGES RH IMMUNE
IG
PLASMA
CSL BEHRING LLC
GAMUNEX
1 GRAM 13533-0800-12
VIAL
IVIG
IG
PLASMA
GRIFOLS USA, LLC
300 UG (1500 IU)
GAMUNEX
2.5 GRAM 13533-0800-15
VIAL
IVIG
IG
PLASMA
GRIFOLS USA, LLC
WINRHO
70257-0330-51
VIAL
RH IMMUNE
IG
PLASMA SAOL THERAPEUTICS, INC.
GAMUNEX
5 GRAM 13533-0800-20
VIAL
IVIG
IG
PLASMA
GRIFOLS USA, LLC
500 UG (2500 IU)
WINRHO
70504-3500-02
VIAL
RH IMMUNE
IG
PLASMA SAOL THERAPEUTICS, INC.
GAMUNEX
10 GRAM 13533-0800-71
VIAL
IVIG
IG
PLASMA
GRIFOLS USA, LLC
GAMUNEX
20 GRAM 13533-0800-24
VIAL
IVIG
IG
PLASMA
GRIFOLS USA, LLC
1000 UG (5000 IU)
WINRHO
70257-0310-51
VIAL
RH IMMUNE
IG
PLASMA SAOL THERAPEUTICS, INC.
GAMUNEX
40 GRAM 13533-0800-40
VIAL
IVIG
IG
PLASMA
GRIFOLS USA, LLC
17
IG IMMUNOOGY PRODUCTS - IMMUNOGLOBULIN Product Name Package Size NDC #
IG IMMUNOOGY PRODUCTS - IMMUNOGLOBULIN Product Name Package Size NDC #
Presentation Product Category Subcategory Derivation
Manufacturer
Presentation Product Category Subcategory Derivation
Manufacturer
OCTAGAM 5%
1% 5 GRAM 68982-0840-01
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
HIZENTRA PFS
1 GRAM 44206-0456-21
VIAL
SUBQ
IG
PLASMA
CSL BEHRING LLC
OCTAGAM 5%
2.5% 5 GRAM 68982-0840-02
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
HIZENTRA PFS
2 GRAM 44206-0457-22
VIAL
SUBQ
IG
PLASMA
CSL BEHRING LLC
OCTAGAM 5%
5% 5 GRAM 68982-0840-03
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
HIZENTRA PFS
4 GRAM 44206-0458-24
VIAL
SUBQ
IG
PLASMA
CSL BEHRING LLC
OCTAGAM 5%
5% 10 GRAM 68982-0840-04
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
HYQVIA
2.5 GRAM 00944-2510-02
VIAL
SUBQ
IG
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
OCTAGAM 10%
10% 2 GRAM 68982-0850-01
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
HYQVIA
5 GRAM 00944-2511-02
VIAL
SUBQ
IG
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
OCTAGAM 10%
10% 5 GRAM 68982-0850-02
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
OCTAGAM 10%
10% 10 GRAM 68982-0850-03
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
HYQVIA
10 GRAM 00944-2512-02
VIAL
SUBQ
IG
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
OCTAGAM 10%
10% 20 GRAM 68982-0850-04
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
OCTAGAM 10%
10% 30 GRAM 68982-0850-05
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
HYQVIA
20 GRAM 00944-2513-02
VIAL
SUBQ
IG
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
PANZYGA
2.5 GRAM 68982-0820-02
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
HYQVIA
30 GRAM 00944-2514-02
VIAL
SUBQ
IG
PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
PANZYGA
5 GRAM 68982-0820-03
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
XEMBIFY
1 GRAM 13533-0810-05
VIAL
SUBQ
IG
PLASMA
GRIFOLS USA, LLC
PANZYGA
10 GRAM 68982-0820-04
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
XEMBIFY
2 GRAM 13533-0810-10
VIAL
SUBQ
IG
PLASMA
GRIFOLS USA, LLC
PANZYGA
20 GRAM 68982-0820-05
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
XEMBIFY
4 GRAM 13533-0810-20
VIAL
SUBQ
IG
PLASMA
GRIFOLS USA, LLC
PANZYGA
30 GRAM 68982-0820-06
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
XEMBIFY
10 GRAM 13533-0810-50
VIAL
SUBQ
IG
PLASMA
GRIFOLS USA, LLC
PRIGEN
5 GRAM 44206-0436-05
VIAL
IVIG
IG
PLASMA
CSL BEHRING LLC
PRIGEN
10 GRAM 44206-0437-10
VIAL
IVIG
IG
PLASMA
CSL BEHRING LLC
PRIGEN
20 GRAM 44206-0438-20
VIAL
IVIG
IG
PLASMA
CSL BEHRING LLC
NP NEUROLOGY PRODUCTS Product Name Package Size NDC #
PRIGEN
40 GRAM 44206-0439-40
VIAL
IVIG
IG
PLASMA
CSL BEHRING LLC
Product Category Subcategory Derivation
Presentation
Manufacturer
SUBCUTANEOUS IMMUNE GLOBULIN
AMYOTROPHIC LATERAL SCLEROSIS (ALS)
CUTAQUIG
1 GRAM 00069-1061-02
VIAL
SUBQ
IG
PLASMA
PFIZER, INC.
CUTAQUIG
2 GRAM 00069-1476-02
VIAL
SUBQ
IG
PLASMA
PFIZER, INC.
RADICAVA
30MG/100 ML 70510-2171-02
CARTON RADICAVA SPECIALTY RECOMBINANT MITSUBISHI TANABE PHARMA AMERICA, INC.
CUTAQUIG
4 GRAM 00069-1509-02
VIAL
SUBQ
IG
PLASMA
PFIZER, INC.
CUTAQUIG
8 GRAM 00069-1965-02
VIAL
SUBQ
IG
PLASMA
PFIZER, INC.
CUTAQUIG
1 GRAM 68982-0810-01
VIAL
SUBQ
IG
PLASMA
OCTAPHARMA USA
CUTAQUIG
2 GRAM 68982-0810-03
VIAL
SUBQ
IG
PLASMA
OCTAPHARMA USA
CUTAQUIG
4 GRAM 68982-0810-05
VIAL
SUBQ
IG
PLASMA
OCTAPHARMA USA
CUTAQUIG
8 GRAM 68982-0810-06
VIAL
SUBQ
IG
PLASMA
OCTAPHARMA USA
HIZENTRA
1 GRAM 44206-0451-01
VIAL
SUBQ
IG
PLASMA
CSL BEHRING LLC
HIZENTRA
2 GRAM 44206-0452-02
VIAL
SUBQ
IG
PLASMA
CSL BEHRING LLC
HIZENTRA
4 GRAM 44206-0454-04
VIAL
SUBQ
IG
PLASMA
CSL BEHRING LLC
HIZENTRA
10 GRAM 44206-0455-10
VIAL
SUBQ
IG
PLASMA
CSL BEHRING LLC
19
SP SPECIALTY PRODUCTS Product Name Package Size NDC #
Product Category Subcategory Derivation
Presentation
Manufacturer
Interested in having your ad featured in our catalog? Contact marketing@biocare.com to learn more!
SNAKE BITE
1 CARTON = 1 VIAL
ANAVIP
66621-0790-02
VIAL
SPECIALTY SPECIALTY RECOMBINANT MCKESSON SPECIALTY CARE DISTRIBUTION
CROFAB
2 ML
50633-0110-12 CARTON, 2 VIALS PER SPECIALTY SPECIALTY
BTG INTERNATIONAL, INC.
HEREDITARY ANGIOEDEMA (HAE)
BERINERT
500 UNITS 63833-0825-02
VIAL
SPECIALTY SPECIALTY PLASMA
CSL BEHRING LLC
PROTEIN C DEFICIENCY
CEPROTIN
500 IU 00944-4177-05
VIAL
SPECIALTY SPECIALTY PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
CEPROTIN
1000 IU 00944-4179-10
VIAL
SPECIALTY SPECIALTY PLASMA TAKEDA PHARMACEUTICALS AMERICAS, INC.
Download Media Kit
VACCINE
PACK, 10 VIALS PER
ENGERIX
1 ML
58160-0821-11
VACCINE
SPECIALTY RECOMBINANT
HENRY SCHEIN, INC.
ULCERATIVE COLITIS & CROHN'S DISEASE
TAKEDA PHARMACEUTICALS AMERICAS, INC.
ENTYVIO
300MG 20ML 64764-0300-20
VIAL
SPECIALTY SPECIALTY MONOCLONAL ANTIBODY
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
SOLIRIS
300MG/ML 25682-0001-01
VIAL
SPECIALTY SPECIALTY
ALEXION
BIOSURGICAL
BAXTER HEALTHCARE CORPORATION BAXTER HEALTHCARE CORPORATION BAXTER HEALTHCARE CORPORATION BAXTER HEALTHCARE CORPORATION BAXTER HEALTHCARE CORPORATION BAXTER HEALTHCARE CORPORATION BAXTER HEALTHCARE CORPORATION BAXTER HEALTHCARE CORPORATION
FLOSEAL
5ML
85412-5237-38
EACH FIBRIN SEALANT SPECIALTY PLASMA
SD VALUPAK 2 ML
TISSEEL
00338-4210-02
EACH FIBRIN SEALANT SPECIALTY PLASMA
TISSEEL
2 ML
00338-4301-02
EACH FIBRIN SEALANT SPECIALTY PLASMA
TISSEEL
4 ML
00338-4302-04
EACH FIBRIN SEALANT SPECIALTY PLASMA
TISSEEL
10 ML
00338-4303-10
EACH FIBRIN SEALANT SPECIALTY PLASMA
TISSEEL
FROZEN 2 ML 00944-8402-02
EACH FIBRIN SEALANT SPECIALTY PLASMA
TISSEEL
FROZEN 4 ML 00338-8402-04
EACH FIBRIN SEALANT SPECIALTY PLASMA
TISSEEL
FROZEN 10 ML 00338-8402-10
EACH FIBRIN SEALANT SPECIALTY PLASMA
21
Page 1 Page 2-3 Page 4-5 Page 6-7 Page 8-9 Page 10-11 Page 12-13 Page 14-15 Page 16-17 Page 18-19 Page 20-21 Page 22-23 Page 24Powered by FlippingBook